Clinical Trials List
2010-12-01 - 2012-12-31
Phase III
Terminated10
ICD-10D07.5
Carcinoma in situ of prostate
ICD-9233.4
Carcinoma in situ of prostate
-
Trial Applicant
PPD DEVELOPMENT (HK) LIMITED
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- HONG-JENG YU Division of Urology
- SHUO-MENG WANG Division of Urology
- 劉詩彬 Division of Urology
- - - Division of Urology
- Hong-Chiang Chang Division of Urology
- 戴槐青 Division of Urology
- Yeong-Shiau Pu Division of Urology
- - - Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chi-Ping Huang Division of Urology
- Wen-Chi Chen Division of Urology
- Chin-Chung Yeh Division of Urology
- Chao-Hsiang Chang Division of Urology
- Chi-Rei Yang Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Tzu-Ping Lin Division of Urology
- Hsiao-Jen Chung Division of Urology
- Chih-Chieh Lin Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Rita cheng Division of Urology
- 張英勛 Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chuan-Shu Chen Division of Urology
- Jian-Ri Li Division of Urology
- Shian-Shiang Wang Division of Urology
- Cheng-Kuang Yang Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
110 participants
-
Global
110 participants
